Technical Analysis for EARS - Auris Medical Holding AG

Grade Last Price % Change Price Change
D 3.14 -0.32% -0.01
EARS closed down 0.32 percent on Tuesday, January 26, 2021, on 24 percent of normal volume.

Trend Table & Recent EOD Signals

ADX Long Term Intermediate Term Short Term
Very Strong Up Up Up
Historical EARS trend table...

Date Alert Name Type % Chg
Upper Bollinger Band Walk Strength 0.00%
Upper Bollinger Band Touch Strength 0.00%
Above Upper BB Strength -0.32%
Upper Bollinger Band Touch Strength -0.32%
MACD Bullish Signal Line Cross Bullish -4.27%
Pocket Pivot Bullish Swing Setup -4.27%
Wide Range Bar Range Expansion -4.27%
BB Squeeze Ended Range Expansion -4.27%
Above Upper BB Strength -4.27%
Up 3 Days in a Row Strength -4.27%
Older End-of-Day Signals for EARS ...

   Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

Alert Time
Gap Up Closed about 16 hours ago
Fell Below Upper Bollinger Band about 16 hours ago
60 Minute Opening Range Breakdown about 16 hours ago
60 Minute Opening Range Breakout about 21 hours ago
Up 10% about 21 hours ago
View Earlier Intraday Alerts

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.


Auris Medical Holding AG Description

Auris Medical Holding AG, a clinical-stage biopharmaceutical company, focuses on the development of novel products for the treatment of inner ear disorders. Its lead product candidate includes AM-101, which is in Phase III clinical trials for treating acute inner ear tinnitus. The company is also developing AM-111 for the treatment of acute sensorineural hearing loss, as well as for Meniere diseases; and other development programs comprising AM-102 and AM-123 that are in preclinical studies. It has a collaboration and license agreement with Xigen S.A. to develop, manufacture, and commercialize pharmaceutical products, and drug delivery devices and formulations for the treatment of inner ear disorders. The company was formerly known as Auris Medical AG and changed its name to Auris Medical Holding AG in April 2014. Auris Medical Holding AG was founded in 1998 and is headquartered in Zug, Switzerland.


Sector: Healthcare
Industry: Biotechnology
Keywords: Biopharmaceutical Pharmaceutical Products Symptoms Drug Delivery Hearing Nervous System Perception Hearing Loss Novel Products Sensorineural Hearing Loss Tinnitus Auditory System Drug Delivery Devices Inner Ear

Is EARS a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength


Indicator Value
52 Week High 6.6
52 Week Low 0.65
Average Volume 7,963,136
200-Day Moving Average 1.31
50-Day Moving Average 2.43
20-Day Moving Average 2.75
10-Day Moving Average 2.85
Average True Range 0.34
ADX 57.14
+DI 41.49
-DI 6.41
Chandelier Exit (Long, 3 ATRs ) 2.80
Chandelier Exit (Short, 3 ATRs ) 3.53
Upper Bollinger Band 3.15
Lower Bollinger Band 2.35
Percent B (%b) 0.99
BandWidth 28.91
MACD Line 0.15
MACD Signal Line 0.12
MACD Histogram 0.0292
Fundamentals Value
Market Cap 22.26 Million
Num Shares 7.09 Million
EPS -1.33
Price-to-Earnings (P/E) Ratio -2.37
Price-to-Sales 0.00
Price-to-Book 1.37
PEG Ratio 0.00
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 3.81
Resistance 3 (R3) 3.88 3.73 3.70
Resistance 2 (R2) 3.73 3.56 3.69 3.66
Resistance 1 (R1) 3.44 3.45 3.36 3.36 3.62
Pivot Point 3.29 3.29 3.25 3.25 3.29
Support 1 (S1) 2.99 3.12 2.92 2.92 2.66
Support 2 (S2) 2.84 3.01 2.80 2.62
Support 3 (S3) 2.55 2.84 2.58
Support 4 (S4) 2.47